Search
for
Sort by
Research 211–240 of 923
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Real-world evidence in alopecia areata treatment: A narrative review
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Diffuse Lichen Planopilaris Masquerading as Diffuse Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Treatment options for alopecia: an update, looking to the future
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- Alopecia areata - need for a revision in morphological classification and scoring
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Nonscarring Alopecias
- What's missing from this picture? An approach to alopecia in children
- The role of fractional laser‐assisted drug delivery in enhancing the efficacy of topical bimatoprost solution in the treatment of alopecia areata: An intra‐patient comparative randomized clinical trial
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Diagnosis and Management of Alopecia in Children
- New drugs under investigation for the treatment of alopecias
- Clinical Approach to the Patient With Alopecia
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Alopecia Areata–Specific Patient-Reported Outcome Measures
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.